METHODS	In a double-blind study , desipramine or placebo was added for 6 or 10 weeks to the treatment of 30 patients with obsessive-compulsive disorder whose symptoms were refractory to SSRI treatment ( fluvoxamine , fluoxetine , or sertraline ) alone .\